Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Nierhaus

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Critical Care Medicine|December 13, 2007
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shockK Georg Kreymann, Geraldine de Heer, Axel Nierhaus, et al.
Biomed Research International|November 11, 2016
Sepsis: Diagnostic and Therapeutic ChallengesZsolt Molnár, Evangelos J Giamarellos-Bourboulis, Anand Kumar, et al.
Inflammation & Allergy Drug Targets|January 28, 2012
Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS)Axel Nierhaus, Jo Linssen, Dominic Wichmann, et al.
Deutsche Medizinische Wochenschrift (1946)|July 31, 2018
[Lactic acidosis - update 2018]Stefan Kluge, Geraldine de Heer, Dominik Jarczak, et al.
Annals of Intensive Care|October 7, 2020
Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsisAxel Nierhaus, Giorgio Berlot, Detlef Kindgen-Milles, et al.
Critical Care (London, England)|August 21, 2018
Predicting the requirement for renal replacement therapy in intensive care patients with sepsisAxel Nierhaus, Frank Bloos, Darius Cameron Wilson, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|June 8, 2017
Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center studySigrun Friesecke, Stephanie-Susanne Stecher, Stefan Gross, et al.
Journal of Clinical Medicine|December 9, 2023
Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus StatementSteffen Mitzner, Klaus Kogelmann, Can Ince, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2002
41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseasesDjordje Atanackovic, Axel Nierhaus, Michael Neumeier, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 19, 2007
Monitoring of whole-body hyperthermia with transesophageal echocardiography (TEE)Antje Fippel, Alexandra Von Sandersleben, Katrin Bangert, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Critical Care Medicine|December 13, 2007
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shockK Georg Kreymann, Geraldine de Heer, Axel Nierhaus, et al.
Biomed Research International|November 11, 2016
Sepsis: Diagnostic and Therapeutic ChallengesZsolt Molnár, Evangelos J Giamarellos-Bourboulis, Anand Kumar, et al.
Inflammation & Allergy Drug Targets|January 28, 2012
Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS)Axel Nierhaus, Jo Linssen, Dominic Wichmann, et al.
Deutsche Medizinische Wochenschrift (1946)|July 31, 2018
[Lactic acidosis - update 2018]Stefan Kluge, Geraldine de Heer, Dominik Jarczak, et al.
Annals of Intensive Care|October 7, 2020
Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsisAxel Nierhaus, Giorgio Berlot, Detlef Kindgen-Milles, et al.
Critical Care (London, England)|August 21, 2018
Predicting the requirement for renal replacement therapy in intensive care patients with sepsisAxel Nierhaus, Frank Bloos, Darius Cameron Wilson, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|June 8, 2017
Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center studySigrun Friesecke, Stephanie-Susanne Stecher, Stefan Gross, et al.
Journal of Clinical Medicine|December 9, 2023
Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus StatementSteffen Mitzner, Klaus Kogelmann, Can Ince, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2002
41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseasesDjordje Atanackovic, Axel Nierhaus, Michael Neumeier, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 19, 2007
Monitoring of whole-body hyperthermia with transesophageal echocardiography (TEE)Antje Fippel, Alexandra Von Sandersleben, Katrin Bangert, et al.
Pageof 10